Literature DB >> 15115227

Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.

R R Sharma1, Ramandeep Cheema, Meenu Vajpayee, Usha Rao, Sudarshan Kumar, Neelam Marwaha, S K Agnihotri.   

Abstract

BACKGROUND: Transfusion of safe blood requires a safe donor. The voluntary donor movement encompasses the concept of a donor who is free from transfusion transmissible infections. It is now mandatory to screen blood for hepatitis B surface antigen, antibodies to HIV-1 and HIV-2, antibodies to hepatitis C virus, syphilis and malarial parasites.
METHODS: Between 1996 and 2002, 235 461 donors were screened for markers of hepatitis B virus, and HIV-1 and HIV-2 using commercially available ELISA kits, VDRL test for syphilis and Geimsa stain for the malarial parasite, respectively. A total of 56 476 donors were screened for hepatitis C virus antibodies from June 2001 to December 2002, using third-generation ELISA kits.
RESULTS: The proportion of voluntary donors increased from 47% to 56% during the study period. The prevalence of HIV showed a steady increase from 0.16% in 1996 to 0.3% in 2002. The prevalence of hepatitis B surface antigen decreased from 1.55% to 0.99%. VDRL reactivity did not show any trend and ranged between 0.11% and 0.66%. Hepatitis C virus antibodies showed a prevalence of 0.4%. The prevalence of all markers was significantly less in voluntary donors. Among the voluntary donors, transfusion transmissible disease markers were significantly less in student donors as compared to other donors.
CONCLUSION: A change-over to a voluntary donor service would considerably reduce the number of infectious donors and, among voluntary donors, student donors are the safest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115227

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  11 in total

1.  Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India.

Authors:  L Jagannathan; M Chaturvedi; S Mudaliar; T Kamaladoss; M Rice; E L Murphy
Journal:  Transfus Med       Date:  2010-08-18       Impact factor: 2.019

Review 2.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 3.  Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis.

Authors:  Ashish Batham; Manoj Anand Gupta; Pallav Rastogi; Shubham Garg; V Sreenivas; Jacob M Puliyel
Journal:  Indian J Pediatr       Date:  2010-01-28       Impact factor: 1.967

4.  Anti-HBc screening in Indian blood donors: still an unresolved issue.

Authors:  Hari-Krishan Dhawan; Neelam Marwaha; Ratti-Ram Sharma; Yogesh Chawla; Beenu Thakral; Karan Saluja; Sanjeev-Kumar Sharma; Manish-K Thakur; Ashish Jain
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

5.  Implementing fourth generation human immunodeficiency virus enzyme-linked immunosorbent assay: One step forward in blood safety.

Authors:  Prasun Bhattacharya; Ravneet Kaur
Journal:  Asian J Transfus Sci       Date:  2013-07

6.  Seroprevalence of anti-HCV antibodies among blood donors of north India.

Authors:  R N Makroo; Rimpreet Singh Walia; Mohit Chowdhry; Aakanksha Bhatia; Vikas Hegde; N L Rosamma
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

7.  Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatits C virus in blood donors of Jammu Province: A tertiary care centre experience.

Authors:  Meena Sidhu; Urvershi Kotwal; Raman Kapoor; Tilakraj Raina
Journal:  Asian J Transfus Sci       Date:  2013-07

8.  Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay.

Authors:  Sheetal Malhotra; Neelam Marwaha; Karan Saluja
Journal:  Asian J Transfus Sci       Date:  2013-07

Review 9.  Family donors are critical and legitimate in developing countries.

Authors:  Jean-Pierre Allain; Cees Th Smit Sibinga
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

10.  Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India.

Authors:  Naveen Agnihotri; Neelam Marwaha; Ratti R Sharma
Journal:  Asian J Transfus Sci       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.